US Patent 7550480 Compounds
Patent 7550480 was granted and assigned to Smithkline Beecham Limited on June, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+363 characters)
Article
Patent abstract
Novel substituted 1,5,7-trisubstituted-1,8-napthyridin-2(1H)-one compounds; 1,5,7 trisubstituted-1,6-napthyridine-2-(1H)-one compounds and 1,5,7-trisubstituted quinoline-2(1H)-one compounds, processes for the preparation thereof, the use thereof in treating CSBP/p38 kinase mediated diseases and pharmaceutical compositions for use in such therapy.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07550480 Compounds US Patent 7550480 Compounds
Infobox
Patent Number
0755048000
Patent Number
755048000
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075504800
Date of Patent
June 23, 2009
0Patent Application Number
105455650
Date Filed
February 13, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075504800
Date of Patent
June 23, 2009
0Patent Application Number
105455650
Date Filed
February 13, 2004
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07550480 Compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07550480
Date of patent
June 23, 2009
Patent application number
10545565
Date Filed
February 13, 2004
Patent primary examiner
Find more entities like US Patent 7550480 Compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
